英国过敏犀牛结膜炎,喘和湿疹的流行趋势和危险因素
Lavanya Diwakar1,2, Anuradhaa Subramanian3, Divya K Shah4
1Institute of Applied Health Research, University of Birmingham, B15 2TT, Birmingham, UK. l.diwakar@bham.ac.uk.
概括
过敏性犀牛结膜炎 (ARC),喘和湿疹的患病率在英国成年人中增加,但在十年内在儿童中下降. 其他过敏会显著增加这些常见疾病的风险.
科学领域:
- 公共卫生 公共卫生
- 流行病学 流行病学
- 临床医学 临床医学
背景情况:
- 过敏犀牛结膜炎 (ARC),喘和湿疹是常见的疾病,具有显著的发病率.
- 这些过敏性疾病在个体中经常同时发生,其患病率因人口统计学而异.
研究的目的:
- 分析过去十年英国ARC,喘和湿疹的流行趋势.
- 使用初级保健数据识别这些过敏状况的相关风险因素.
主要方法:
- 英国THIN数据库 (2010-2019) 的纵向队列分析.
- 逻辑回归被用来调查ARC,喘和湿疹的诊断风险因素.
主要成果:
- 成年人患ARC,喘和湿疹的患病率上升,而儿童患病率下降.
- 到2018年,英国人口中很大一部分患有以下疾病:1:8成人和1:14儿童患有ARC;1:7成人和1:10儿童患有喘;1:6成人和1:4儿童患有湿疹.
- 患有其他过敏会大大增加患喘,湿疹和ARC的可能性,具有显著的种族和区域差异.
结论:
- 英国面临着由ARC,喘和湿疹造成的重大负担.
- 这些情况往往是复杂的管理,因为它们与其他过敏的关联.
- 这些发现强调了需要改善英国过敏患者的护理途径.
相关概念视频
Asthma-I: Introduction
2.8K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.8K
Asthma-II: Pathophysiology and Classification
2.9K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.9K
Asthma: Pathogenesis and Management
607
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
607
Asthma-III: Symptoms and Complications
2.6K
Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
Classification of Asthma
2.6K
Asthma-IV: Diagnostic and Management
2.6K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.6K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
471
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
471


